Pressmeddelanden från Circio

Bevaka pressreleaser

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

CIRCIO HOLDING ASA – SHARE CAPITAL INCREASE REGISTERED FOLLOWING EXERCISE OF WARRANTS AND UNDERWRITTEN PRIVATE PLACEMENT 09 jun 23:12

Circio completes transformational fundraising of NOK 300 million to strengthen its position as the global leader in circular RNA-based gene expression systems 09 jun 07:00

Circio Holding ASA: Last day of the exercise period for the Warrants 04 jun 09:41

Circio Holding ASA – Exercise of Warrants by primary insiders 03 jun 07:00

Circio Holding ASA: Last day of trading in warrants 02 jun 10:33

Circio Holding ASA – Exercise of Warrants by primary insiders 01 jun 07:00

Circio and GenAssist jointly announce gene therapy research collaboration for muscle diseases and in vivo cell therapy 29 maj 07:00

Circio Holding ASA – Exercise of Warrants by primary insiders 28 maj 07:00

Circio hosts live webcast today 28 May 2026 at 10:00 am CEST 27 maj 07:00

Circio and AaviGen jointly announce research collaboration to advance novel gene therapies for heart diseases 26 maj 07:10

Announcement of the terms of the underwriting and the Unused Warrants Option Agreement in connection with the Warrant Program 26 maj 07:05

Commencement of exercise period for the Warrants 26 maj 07:00

Warrants exercise period commences today – potential proceeds to transform Circio into a clinical-stage circular RNA company 22 maj 18:11

Circio Holding ASA: Exercise price for Warrants set at NOK 8.2508 22 maj 07:00

Circio invites to a live webcast on 28 May 2026 to summarize the presentations at ASGCT 2026 and provide an overview of the warrants program 21 maj 07:00

Circio files EPO patent application covering critical aspects of its circVec platform for enhanced gene and cell therapy 15 maj 22:15

Circio presents new and extensive circVec data at ASGCT supporting substantial AAV dose reduction 11 maj 13:29

Circio Holding ASA: Issuance of restricted stock units (RSUs) to board member 11 maj 12:12

Circio Holding ASA: Registration of share capital increase following exercise of options and settlement of RSUs 11 maj 11:08

Circio Holding ASA: Issuance of restricted stock units (RSUs) to the board members 08 maj 16:00

Circio Holding ASA: Minutes from the annual general meeting 2026 07 maj 10:08

Circio Holding ASA: Mandatory notification of trade by primary insiders pertaining to settlement of RSUs 06 maj 14:34

Practical information relating to the warrant program 06 maj 12:48

Circio Holding ASA: Exercise of options, settlement of RSUs and resolutions to increase the share capital 29 apr 07:00

Circio announces research collaboration with the Universidad de Santiago de Compostela’s TraffikGene project to advance non-viral circVec delivery 27 apr 22:30

Circio announces publication of two abstracts selected for presentation at the ASGCT annual meeting 24 apr 19:40

Circio Holding ASA: Cancellation of Subsequent Offering 17 apr 14:15

Circio Holding ASA – Notice of annual general meeting 2026 16 apr 07:00

Mandatory adjustment of RSUs and share options following recently completed rights issue 15 apr 19:47

Circio Holding ASA: Annual Report and Remuneration Report for 2025 15 apr 07:00

Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics 14 apr 11:24

Circio Holding ASA: Registration of share capital increase following private placement of approximately NOK 250 million 08 apr 07:00

Circio Holding ASA: Ex. right to participate in potential subsequent offering today 08 apr 02:59

Circio Holding ASA: Key information relating to potential subsequent offering 08 apr 02:42

Circio announces that it has completed a significantly oversubscribed financing of NOK 250 million 08 apr 02:06

Circio Holding ASA – Key events and financial highlights – 2H 2025 and YTD 2026 26 mar 13:40

Circio enters in vivo cell therapy collaboration with United Immunity 18 mar 14:45

Circio selected for oral presentation at prestigious ASGCT annual meeting 26 feb 07:00

Circio presents groundbreaking in vivo data showing up to 50-fold enhanced circVec-AAV gene expression in eye 19 feb 07:00

Circio invites to R&D and corporate update webcast on 26 February 2026 17 feb 10:33

Circio Holding ASA: Registration of share capital increase following directed issue of NOK 3.6 million 16 feb 07:00

CIRCIO HOLDING ASA: INFORMATION ABOUT WARRANTS AND COMMENCEMENT OF TRADING 14 feb 09:57

Circio announces allocation of stock options to key employees 12 feb 12:19

Circio Holding ASA: Registration of share capital increase following rights issue and private placement 06 feb 11:48

Circio Holding ASA completes directed issue of NOK 3.6 million 30 jan 19:44

Circio Holding ASA – Mandatory notification of trade by primary insiders and close associates related to the rights issue and private placement 30 jan 14:11

Circio Holding ASA – Final results of the oversubscribed rights issue 29 jan 21:43

Circio Holding ASA announces substantially oversubscribed preliminary result of the rights issue 29 jan 09:32

Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders 29 jan 07:00

Circio Holding ASA – Subscription period for the rights issue expires today 28 jan 13:37

Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders 23 jan 07:00

Circio Holding ASA – Last day of trading in subscription rights in the rights issue 22 jan 10:50

Analyst Group publishes initiation report on Circio 21 jan 15:12

Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders 16 jan 14:06

Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders 15 jan 15:12

Circio Holding ASA – Receipt of subscription rights in the rights issue by primary insiders and their close associates 15 jan 07:00

Circio Holding ASA – Commencement of the subscription period for the rights issue 13 jan 12:23

Circio Holding ASA – Approval and publication of prospectus for the rights issue 13 jan 07:00

Circio Holding ASA – Ex. subscription rights today 12 jan 22:19

Circio Holding ASA – Minutes from the extraordinary general meeting 2026 and approval of Rights Issue 12 jan 15:30

Circio invites to live webcast on 15 January 2026 to provide information about the upcoming rights issue 12 jan 15:15

Circio Holding ASA – Extraordinary general meeting held, all agenda items approved 09 jan 07:00

Circio Holding ASA – Updated key information relating to the rights issue 07 jan 17:00

Circio and The University of Texas Medical Branch jointly announce collaboration to evaluate circVec for the treatment of infectious diseases 23 dec 2025 09:11

Correction: Circio Holding ASA – Updated information to the notice of extraordinary general meeting 2026 23 dec 2025 09:02

Circio Holding ASA – Updated information to the notice of extraordinary general meeting 2025 19 dec 2025 14:24

Circio Holding ASA – Notice of extraordinary general meeting on 12 January 2026 08 dec 2025 10:00

Circio Holding ASA – Key information related to the rights issue 08 dec 2025 07:00

Circio announces 88% underwritten and presubscribed NOK 50 million rights issue with strong support from existing shareholders 24 nov 2025 07:00

Circio presents data that further strengthens and broadens its circVec circular RNA expression platform 17 nov 2025 14:00

Circio issues invitation to R&D and corporate update webcast on 24 November 2025 19 okt 2025 21:45

Circio Holding ASA – Bond conversion and additional trading restrictions 17 okt 2025 16:39

Circio Holding ASA: Requested Conversion of Convertible Bonds 15 okt 2025 11:14

Circio Holding ASA: Requested Conversion of Convertible Bonds 08 okt 2025 07:00

Circio presents comprehensive circVec in vivo data package demonstrating 40-fold improvement over conventional AAV gene delivery at ESGCT 2025 06 okt 2025 12:07

Circio Holding ASA: Requested Conversion of Convertible Bonds 01 okt 2025 16:55

Circio Holding ASA – Approval and publication of prospectus for potential future share issues and conversion of convertible bonds 01 okt 2025 07:00

Circio to present comprehensive circVec-AAV in vivo data package at ESGCT 2025 09 sep 2025 09:53

Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds 05 sep 2025 10:29

Circio Holding ASA - Conversion of Convertible Bonds and funding requested under Additional Financing Commitment from Atlas 28 aug 2025 07:00

Circio presents new circVec-AAV vectors showing up to 40x enhanced activity in first half year report webcast 21 aug 2025 07:00

Circio invites to first half 2025 report and R&D update webcast on 28 August 04 aug 2025 10:57

Circio Holding ASA – Funding requested under additional financing commitment from Atlas 07 jul 2025 07:00

Circio expanding its R&D operations in Stockholm to accelerate circVec development 30 jun 2025 07:00

NeoRegen Biotech and Circio advance circular RNA delivery collaboration into in vivo stage 16 jun 2025 07:00

TG01 mutant RAS cancer vaccine data showing clinical benefit in multiple myeloma presented at EHA 2025 28 maj 2025 07:00

Circio presents new and differentiating circVec data and corporate update in live webcast 22 maj 2025 07:00

Circio invites to R&D and corporate update webcast on 28 May 2025 14 maj 2025 01:00

Circular RNA innovator Circio presents strengthened circVec gene therapy data at ASGCT 2025 06 maj 2025 07:00

Circular RNA innovator Circio to present strengthened circVec gene therapy data at ASGCT 2025 11 apr 2025 20:00

Circio Holding ASA: Annual Report 2024 - Correction to ESEF-file name 11 apr 2025 18:54

Circio Holding ASA: Annual Report 2024 10 apr 2025 23:25

Circio Holding ASA: Annual Report 2024 03 apr 2025 07:00

Entos Pharmaceuticals and Circio initiate collaboration to test novel platform for circVec circular RNA delivery 26 mar 2025 08:40

Circio presents R&D and corporate update in live webcast 19 mar 2025 10:00

Circio invites to corporate update webcast on 26 March 2025 05 mar 2025 11:00

Circio presents results that further validate the circVec circular RNA platform at two international industry conferences 03 mar 2025 07:00

Circio´s leading position in circular RNA therapeutics highlighted by continued broad coverage in international life science industry media 26 feb 2025 07:00

Circio invited to present advantages of circVec circular RNA technology at international industry conferences 21 jan 2025 07:00

4basebio partners with Circio to build and test circVec synthetic DNA vectors for genetic medicine and vaccines